RET ONCOGENE ACTIVATION IN HUMAN THYROID NEOPLASMS IS RESTRICTED TO THE PAPILLARY CANCER SUBTYPE

被引:333
作者
SANTORO, M
CARLOMAGNO, F
HAY, ID
HERRMANN, MA
GRIECO, M
MELILLO, R
PIEROTTI, MA
BONGARZONE, I
DELLAPORTA, G
BERGER, N
PEIX, JL
PAULIN, C
FABIEN, N
VECCHIO, G
JENKINS, RB
FUSCO, A
机构
[1] MAYO CLIN & MAYO FDN,DIV ENDOCRINOL,ROCHESTER,MN 55905
[2] MAYO CLIN & MAYO FDN,DIV INTERNAL MED & LAB GENET,ROCHESTER,MN 55905
[3] IST NAZL TUMORI,DIV ONCOL SPERIMENTALE A,I-20133 MILAN,ITALY
[4] HOP ANTIQUAILLE,SERV CHIRURG,ANAT PATHOL LAB,F-69321 LYONS 05,FRANCE
[5] HOP J COURMONT ST EUGENIE,CYTOL LAB,F-69310 PIERRE BENITE,FRANCE
[6] UNIV REGGIO CALABRIA,FAC MED & CHIRURG CATANZARO,DIPARTIMENTO MED SPERIMENTALE & CLIN,I-88100 CATANZARO,ITALY
关键词
CARCINOMA; GENE REARRANGEMENT; RET PROTOONCOGENE; TYROSINE KINASE; PTC;
D O I
10.1172/JCI115743
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
We have recently reported the activation of a new oncogene in human papillary thyroid carcinomas. This oncogene, papillary thyroid carcinoma (PTC), is a novel rearranged version of the ret tyrosine-kinase protooncogene. Thyroid neoplasms include a broad spectrum of malignant tumors, ranging from well-differentiated tumors to undifferentiated anaplastic carcinomas. To determine the frequency of ret oncogene activation, we analyzed 286 cases of human thyroid tumors of diverse histologic types. We found the presence of an activated form of the ret oncogene in 33 (19%) of 177 papillary carcinomas. By contrast, none of the other 109 thyroid tumors, which included 37 follicular, 15 anaplastic, and 18 medullary carcinomas, and 34 benign lesions, showed ret activation.
引用
收藏
页码:1517 / 1522
页数:6
相关论文
共 40 条
[1]   MOST HUMAN CARCINOMAS OF THE EXOCRINE PANCREAS CONTAIN MUTANT C-K-RAS GENES [J].
ALMOGUERA, C ;
SHIBATA, D ;
FORRESTER, K ;
MARTIN, J ;
ARNHEIM, N ;
PERUCHO, M .
CELL, 1988, 53 (04) :549-554
[2]   THE MOLECULAR-GENETICS OF CANCER [J].
BISHOP, JM .
SCIENCE, 1987, 235 (4786) :305-311
[3]  
BONGARZONE I, 1989, ONCOGENE, V4, P1457
[4]   PREVALENCE OF RAS GENE-MUTATIONS IN HUMAN COLORECTAL CANCERS [J].
BOS, JL ;
FEARON, ER ;
HAMILTON, SR ;
VERLAANDEVRIES, M ;
VANBOOM, JH ;
VANDEREB, AJ ;
VOGELSTEIN, B .
NATURE, 1987, 327 (6120) :293-297
[5]  
DONGHI R, 1989, ONCOGENE, V4, P321
[6]   ANALYSIS OF RAS GENE-MUTATIONS IN ACUTE MYELOID-LEUKEMIA BY POLYMERASE CHAIN-REACTION AND OLIGONUCLEOTIDE PROBES [J].
FARR, CJ ;
SAIKI, RK ;
ERLICH, HA ;
MCCORMICK, F ;
MARSHALL, CJ .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1988, 85 (05) :1629-1633
[7]   A NEW ONCOGENE IN HUMAN THYROID PAPILLARY CARCINOMAS AND THEIR LYMPH-NODAL METASTASES [J].
FUSCO, A ;
GRIECO, M ;
SANTORO, M ;
BERLINGIERI, MT ;
PILOTTI, S ;
PIEROTTI, MA ;
DELLAPORTA, G ;
VECCHIO, G .
NATURE, 1987, 328 (6126) :170-172
[8]   PTC IS A NOVEL REARRANGED FORM OF THE RET PROTO-ONCOGENE AND IS FREQUENTLY DETECTED INVIVO IN HUMAN THYROID PAPILLARY CARCINOMAS [J].
GRIECO, M ;
SANTORO, M ;
BERLINGIERI, MT ;
MELILLO, RM ;
DONGHI, R ;
BONGARZONE, I ;
PIEROTTI, MA ;
DELLAPORTA, G ;
FUSCO, A ;
VECCHIO, G .
CELL, 1990, 60 (04) :557-563
[9]   CYTOGENETIC AND MOLECULAR GENETIC-STUDIES OF FOLLICULAR AND PAPILLARY THYROID CANCERS [J].
HERRMANN, MA ;
HAY, ID ;
BARTELT, DH ;
RITLAND, SR ;
DAHL, RJ ;
GRANT, CS ;
JENKINS, RB .
JOURNAL OF CLINICAL INVESTIGATION, 1991, 88 (05) :1596-1604
[10]  
ISHIZAKA Y, 1989, ONCOGENE, V4, P789